Get A Quote

Request A Quote

*We respect your confidentiality and all information are protected.

Does the use of platelet rich plasma reduce the donor site morbidity in patients having a patellar tendon graft harvesting for acl reconstruction?

Contact Us For Test samples

Our team is here to help you find what you need. Let’s get you connected today.

Anterior cruciate ligament (ACL) reconstruction is a common surgical procedure used to treat ACL injuries. One of the most common graft options is the patellar tendon graft, which involves harvesting the central third of the patellar tendon to reconstruct the ACL. However, this procedure can result in significant donor site morbidity, including pain, weakness, and decreased range of motion.

Platelet-rich plasma (PRP) therapy is a non-surgical treatment that uses the patient’s own blood to promote healing and reduce inflammation. It contains a concentrated amount of growth factors and cytokines that can stimulate tissue repair and regeneration.

Several studies have investigated the use of PRP to reduce donor site morbidity in patients undergoing patellar tendon graft harvesting for ACL reconstruction. A systematic review and meta-analysis published in the journal Knee Surgery, Sports Traumatology, Arthroscopy in 2020 found that PRP reduced pain and swelling at the donor site and improved knee function compared to a control group.

Another study published in the American Journal of Sports Medicine in 2017 found that the use of PRP at the patellar tendon harvest site improved postoperative function and reduced pain and stiffness compared to a control group.

The mechanism behind the effectiveness of PRP in reducing donor site morbidity is not yet fully understood, but it is believed to be related to its ability to enhance tissue regeneration and reduce inflammation. By delivering growth factors and cytokines directly to the injured tissue, PRP can promote healing and reduce pain and inflammation.

In conclusion, the use of PRP therapy appears to be a promising option for reducing donor site morbidity in patients undergoing patellar tendon graft harvesting for ACL reconstruction. However, more research is needed to fully understand its effectiveness and determine the optimal protocol for its use. Patients should always consult with their healthcare provider to determine the best treatment options for their individual needs.

Quick Quotation

Related Articles

Introduction to Platelet-Rich Therapies Explore the revolutionary world of platelet-rich therapies, understanding how these advancements have redefined wound care and what makes Autologous Matrix of Platelet-Rich Fibrin (PRF) stand out. Understanding Wound Care Delve into the complexities of wound healing, the importance of effective care, and how innovative treatments are changing patient outcomes. What is Autologous Matrix of Platelet-Rich Fibrin in Wound Care 
Introduction to PRF and PRP Exploring the revolutionary advancements in dental regenerative therapies, this article compares Platelet-Rich Fibrin (PRF) and Platelet-Rich Plasma (PRP), shedding light on their uses, benefits, and which stands out as the superior choice in modern dentistry. Understanding PRP: Basics and Benefits Delve into the world of PRP, its extraction process, and PRF vs PRP in Dentistry: Which One is Better
Introduction Platelet-Rich Plasma (PRP), Platelet-Rich Fibrin (PRF), and Concentrated Growth Factor (CGF) represent revolutionary steps in the field of regenerative medicine. These autologous products harness the body’s healing capabilities to repair and rejuvenate tissues. This article delves into each of these treatments, exploring their benefits, risks, and applications. What is PRP? Platelet-Rich Plasma (PRP) is PRP, PRF, CGF (Concentrated Growth Factor)

PRP & Needle specialists

Copyright © 2022, KEALOR. Jiangsu, China.